{
    "article_link": "https://doi.org/10.1038/s41467-023-42565-z",
    "data": [
        {
            "id": "data_1",
            "omics": "Epigenomics (Chromatin Accessibility)",
            "link": "https://ngdc.cncb.ac.cn/gsa-human/",
            "format": "FASTQ/BAM",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA002815"
        },
        {
            "id": "data_2",
            "omics": "Genomics (Whole Genome Sequencing)",
            "link": "https://ngdc.cncb.ac.cn/gsa-human/",
            "format": "FASTQ/BAM",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA005668"
        },
        {
            "id": "data_3",
            "omics": "Transcriptomics",
            "link": "https://ngdc.cncb.ac.cn/gsa-human/",
            "format": "FASTQ/BAM",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA000119"
        },
        {
            "id": "data_4",
            "omics": "Histone Modifications (ChIP-seq)",
            "link": "https://ega-archive.org/",
            "format": "BAM",
            "source": "European Genome-phenome Archive (EGA)",
            "public_id": "EGAD00001002421"
        },
        {
            "id": "data_5",
            "omics": "Chromatin Accessibility (B-cell Progenitors)",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE122989",
            "format": "FASTQ/BAM",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE122989"
        },
        {
            "id": "data_6",
            "omics": "Clinical Outcomes (TARGET Cohort)",
            "link": "https://gdc.cancer.gov/about-data/publications",
            "format": "Processed Data",
            "source": "dbGaP",
            "public_id": "phs000464"
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Chromatin Accessibility Landscape Characterization",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_2",
            "analysis_name": "Comparison with B-cell Progenitors",
            "analysis_data": [
                "data_1",
                "data_5"
            ],
            "label": {
                "Sample Type": [
                    "B-ALL",
                    "B-cell Progenitors"
                ]
            }
        },
        {
            "id": "analysis_3",
            "analysis_name": "Subtype-specific Chromatin Accessibility Analysis",
            "analysis_data": [
                "data_1",
                "data_2",
                "data_3"
            ],
            "label": {
                "Subtype": [
                    "ETV6::RUNX1",
                    "Hyperdiploidy",
                    "KMT2A",
                    "BCR::ABL1",
                    "BCR::ABL1-like",
                    "ZNF384"
                ]
            }
        },
        {
            "id": "analysis_4",
            "analysis_name": "Allele-specific Open Chromatin Analysis",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "Allele Status": [
                    "C/T",
                    "G/A"
                ]
            }
        },
        {
            "id": "analysis_5",
            "analysis_name": "Relapse-related Chromatin Accessibility Analysis",
            "analysis_data": [
                "data_1",
                "data_3"
            ],
            "label": {
                "Treatment Phase": [
                    "Diagnosis",
                    "Relapse"
                ]
            }
        },
        {
            "id": "analysis_6",
            "analysis_name": "Survival Analysis (Relapse-free Survival)",
            "analysis_data": [
                "data_1",
                "data_6"
            ],
            "label": {
                "Prognostic Group": [
                    "Group A",
                    "Group B"
                ]
            }
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_1",
            "metrics": "Median ACR Count",
            "value": "138,366",
            "features": [
                "Quies Regions (27.95%)",
                "Enh (31.30%)",
                "TssA (20.38%)",
                "Tx (6.38%)",
                "BivR (4.24%)"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "Shared ACRs with B-cell Progenitors",
            "value": "98.57% (pre-pro B) / 98.35% (pro B)",
            "features": [
                "B-ALL-specific ACRs (585,248)",
                "Overlapping ACRs (103,534)"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "Subtype-specific ACRs",
            "value": "17,981",
            "features": [
                "E2F6 (ETV6::RUNX1 subtype)",
                "MECOM",
                "HOXA9",
                "109 Transcription Factors"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "ASOC Regions",
            "value": "3616 (per sample)",
            "features": [
                "rs7090445 (ARID5B)",
                "rs13401811 (BCL2L11)",
                "556 COSMIC Genes"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "Differential ACRs Between Diagnosis and Relapse",
            "value": "945 (median per subtype)",
            "features": [
                "Relapse-high ACRs (5911)",
                "Relapse-low ACRs (1423)",
                "Drug Response Genes (Imatinib, Etoposide)"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "Relapse-free Survival (RFS) Difference",
            "value": "p = 3.778eâˆ’10 (OS), p = 0.0012 (EFS)",
            "features": [
                "70,573 RFS-related ACRs",
                "603 Target Genes (Stem Cell/Myeloid Progenitor Signatures)"
            ]
        }
    ]
}